Organic & Biomolecular Chemistry
Paper
amide (1e)20 and N-phenyl benzaldehyde imine (1d)21 were
prepared according to literature procedures. The spectroscopic
data of the aforementioned compounds were consistent with
those previously reported.
2 Representative Tamiflu syntheses: (a) S. Abrecht,
M. C. Federspiel, H. Estermann, R. Fischer, M. Karpf,
H.-J. Mair, T. Oberhauser, G. Rimmler, R. Trussardi and
U. Zutter, Chimia, 2007, 61, 93; (b) Y. Fukuta, T. Mita,
N. Fukuda, M. Kanai and M. Shibasaki, J. Am. Chem. Soc.,
2006, 128, 6312; (c) T. Mita, N. Fukuda, F. X. Roca,
M. Kanai and M. Shibasaki, Org. Lett., 2007, 9, 259;
(d) N. Satoh, T. Akiba, S. Yokoshima and T. Fukuyama,
Angew. Chem., Int. Ed., 2007, 46, 5734; (e) B. M. Trost and
T. Zhang, Angew. Chem., Int. Ed., 2008, 47, 1.
3 P. A. S. Lowden, in Aziridines and Epoxides in Organic Syn-
thesis, ed. A. K. Yudin, Wiley-VCH, Weinheim, 2006, ch. 11.
4 W. H. Pearson, B. W. Lian and S. C. Bergmeier, in Compre-
hensive Heterocyclic Chemistry II, ed. A. R. Katritzky,
C. W. Rees and E. F. V. Scriven, Elsevier, Oxford, 1996,
vol. 1A.
5 (a) R. S. Atkinson, Tetrahedron, 1999, 55, 1519;
(b) B. Zwanenburg, Pure Appl. Chem., 1999, 71, 423;
(c) D. Tanner, Angew. Chem., Int. Ed., 1994, 33, 599;
(d) X. E. Hu, Tetrahedron, 2004, 60, 2701; (e) A. Padwa, in
Comprehensive Heterocyclic Chemistry III, ed. A. R. Katritzky,
C. A. Ramsden, E. F. V. Scriven and R. J. K. Taylor, Elsevier,
Oxford, 2008, ch. 1.
General procedure A: synthesis of imines (1c and 14–20)
An oven dried round bottomed flask was charged with 2,4,6-
triisopropylbenzenesulfonamide (1 equiv.), fitted with
a
septum and placed under an atmosphere of argon (balloon).
CH2Cl2 was then added via syringe followed by triethylamine
(3 equiv.) and the appropriate aldehyde (1 equiv.). The result-
ing solution was cooled to
0 °C. Titanium(IV) chloride
(0.5 equiv.) in CH2Cl2 was then added dropwise to the cooled
solution and the resulting solution was allowed to stir for 1 h
at this temperature. The reaction mixture was filtered through
Celite and washed with CH2Cl2. The filtrate was concentrated
in vacuo and the resulting solid was suspended in toluene and
then filtered. The filtrate was then concentrated under reduced
pressure to afford the desired imine which was purified as
required.
Representative example: synthesis of (R)-2-phenyl-1-
(2,4,6-triisopropylbenzenesulfonyl)aziridine (3c)
6 For a comprehensive recent review see: H. Pellissier, Tetra-
hedron, 2010, 66, 1509.
An oven dried round bottomed flask containing a magnetic
stirring bar and (2R,5R)-13 (21.36 mg, 0.063 mmol) was
charged with proton sponge (13.60 mg, 0.063 mmol), 1c
(23.58 mg, 0.063 mmol) and activated 3 Å molecular sieves.
The flask was placed under vacuum for 1 h and then immedi-
ately flushed with argon, fitted with a rubber septum and
placed under an atmosphere of argon (balloon). Freshly dis-
tilled CH2Cl2 (0.79 cm3 – stored over activated 3 Å molecular
sieves) and styrene (7.3 μL, 0.063 mmol), was then added
sequentially via syringe. The resulting solution was cooled to
−78 °C. P2 base (2.0 M in THF, 31.7 μL, 0.063 mmol) was then
added dropwise. After 16 h, the crude material was purified by
column chromatography (8 : 2 hexane–CH2Cl2) to furnish the
desired aziridine 3c as a white solid (22.20 mg, 91%, 23% ee).
M.p. 82–84 °C. [α]2D0 = −7.9 (c 0.16, CH2Cl2, 23% ee).
CSP-HPLC: Chiralpak AD-H (4.6 mm × 25 cm), hexane–IPA:
9.5/0.5, 0.5 mL min−1, RT, UV detection at 220 nm, retention
times: 10.0 min (minor enantiomer) and 12.2 (major enantio-
mer). δH (400 MHz, CDCl3): 1.23–1.28 (m, 18H), 2.37 (d, J 4.4,
1H), 2.90 (septet, J 6.9, 1H), 3.04 (d, J 7.2, 1H), 3.80 (dd, J 4.4,
7.2, 1H), 4.40 (septet, J 6.8, 2H), 7.17 (s, 2H), 7.18–7.21 (m,
2H), 7.26–7.32 (m, 3H). δC (100 MHz, CDCl3): 23.7, 24.9, 25.1,
29.9, 34.4, 36.3, 40.7, 124.0, 126.6, 128.3, 128.6, 131.4 (q),
135.8 (q), 151.4 (q), 153.7 (q). ν (cm−1): 694, 758, 1151, 1313,
1462, 1562, 1602, 2869, 2929, 2957. HRMS (EI): [M]+ Calcd for
C23H31NO2S 385.2076; found 385.2061.
7 Selected recent organocatalytic examples: (a) T. Hashimoto,
N. Uchiyama and K. Maruoka, J. Am. Chem. Soc., 2008, 130,
14380; (b) Y. Zhang, Z. Lu and W. D. Wulff, Synlett, 2009,
2715; (c) T. Akiyama, T. Suzuki and K. Mori, Org. Lett.,
2009, 11, 2445; (d) A. A. Desai and W. D. Wulff, J. Am.
Chem. Soc., 2010, 132, 13100; (e) T. Hashimoto, H. Nakatsu,
K. Yamamoto and K. Maruoka, J. Am. Chem. Soc., 2011,
133, 9730.
8 Recent reviews: (a) V. K. Aggarwal, E. M. McGarrigle and
M. A. Shaw, in Science of Synthesis, ed. G. A. Molander,
Thieme, 2010, vol. 37, p. 311; (b) E. M. McGarrigle,
E. L. Myers, O. Illa, M. A. Shaw, S. L. Riches and
V. K. Aggarwal, Chem. Rev., 2007, 107, 5841; (c) J. R. Fulton,
V. K. Aggarwal and J. de Vicente, Eur. J. Org. Chem., 2005,
1479.
9 (a) A. W. Johnson and R. B. LaCount, J. Am. Chem. Soc.,
1961, 83, 417; (b) E. J. Corey and M. Chaykovsky, J. Am.
Chem. Soc., 1962, 84, 867; (c) V. Franzen and H.-E. Driesen,
Chem. Ber., 1963, 96, 1881; (d) E. J. Corey and
M. Chaykovsky, J. Am. Chem. Soc., 1965, 87, 1353.
10 (a) A.-H. Li, L.-X. Dai and V. K. Aggarwal, Chem. Rev., 1997,
97, 2341; (b) V. K. Aggarwal and J. Richardson, Chem.
Commun., 2003, 2644; (c) V. K. Aggarwal and C. L. Winn,
Acc. Chem. Res., 2004, 37, 611; (d) V. K. Aggarwal,
M. Crimmin and S. Riches, in Science of Synthesis, ed. C.
Forsyth, Thieme, 2008, vol. 37, p. 321.
11 Representative references: (a) T. Saito, M. Sakairi and
D. Akiba, Tetrahedron Lett., 2001, 42, 5451; (b) V. K. Aggarwal,
R. A. Stenson, R. V. H. Jones, R. Fieldhouse and J. Blacker,
Tetrahedron Lett., 2001, 42, 1587; (c) V. K. Aggarwal,
M. Ferrara, C. J. O’Brien, A. Thompson, R. V. H. Jones and
Notes and references
1 V. H. Dahanukar and I. Zavialov, Curr. Opin. Drug Discovery
Dev., 2002, 5, 918.
This journal is © The Royal Society of Chemistry 2013
Org. Biomol. Chem.